Publication:
Assessment of IL-31 levels and disease severity in children with atopic dermatitis

Simple item page
dc.contributor.authorOzceker, D.
dc.contributor.authorBulut, M.
dc.contributor.authorOzbay, A. Celik
dc.contributor.authorDilek, F.
dc.contributor.authorKoser, M.
dc.contributor.authorTamay, Z.
dc.contributor.authorGuler, N.
dc.date.accessioned2020-10-22T20:28:48Z
dc.date.available2020-10-22T20:28:48Z
dc.date.issued2018-07-01T00:00:00Z
dc.description.abstractIntroduction and objectives: Atopic dermatitis is a chronic, relapsing, highly pruritic, inflam- matory skin disease characterized by typical localization with increasing prevalence of 10-20% in children. Pruritus is one of the major diagnostic criteria of atopic dermatitis and also the main complaint altering quality-of-life of affected patients, inducing and aggravating inflammation. Although pruritus is the absolute symptom of AD, the etiology has not been fully explained yet and current antihistamine therapies are ineffective.
dc.identifier.citationOzceker D., Bulut M., Ozbay A. C. , Dilek F., Koser M., Tamay Z., Guler N., -Assessment of IL-31 levels and disease severity in children with atopic dermatitis-, ALLERGOLOGIA ET IMMUNOPATHOLOGIA, cilt.46, ss.322-325, 2018
dc.identifier.doi10.1016/j.aller.2017.10.005
dc.identifier.pubmed29555105
dc.identifier.scopus85043994046
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24818
dc.identifier.wosWOS:000437812300003
dc.titleAssessment of IL-31 levels and disease severity in children with atopic dermatitis
dc.typeArticle
dspace.entity.typePublication
local.avesis.ide8c84f6c-5df1-4215-bf58-a8d0f2667c73
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1

Files

Collections

Yayınlar - Eserler